Imperial College London

DrLiamNestor

Faculty of MedicineDepartment of Brain Sciences

Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 8860liam.nestor

 
 
//

Location

 

E517Burlington DanesHammersmith Campus

//

Summary

 

Summary

Cognitive neuroscientist conducting research in disorders of compulsive consumption - Gut Hormones in Addiction (GHADD). Much of this research is early phase translational experimental medicine - mapping the profile and potential efficacy of medications to modulate brain and behavioural markers in these disorders. Developing key methodologies that particularly exploit cognitive, reward and implicit motivational processes in these disorders - targets for future medication development. Valuable experience working in the pharma industry on early phase translational experimental medicine studies as a cognitive neuroscientist. Based at the Neuropsychopharmacology Unit, Division of Brain Sciences.  

Publications

Journals

Nestor LJ, Paterson LM, Murphy A, et al., 2019, Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and poly-substance dependent individuals, European Journal of Neuroscience, Vol:50, ISSN:0953-816X, Pages:2311-2321

Nestor LJ, Behan B, Suckling J, et al., 2019, Cannabis‐dependent adolescents show differences in global reward‐associated network topology: A functional connectomics approach, Addiction Biology, ISSN:1355-6215

Wilson RP, Colizi M, Bossong MG, et al., 2018, The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the M=monetary incentive delay task, Neuropsychology Review, Vol:28, ISSN:1040-7308, Pages:496-506

Nestor LJ, McCabe E, Jones J, et al., 2017, Shared and divergent neural reactivity to non-drug operant response outcomes in current smokers and ex-smokers., Brain Research, Vol:1680, ISSN:0006-8993, Pages:54-61

Ziauddeen H, Nestor LJ, Subramaniam N, et al., 2017, Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype, Neuropsychopharmacology, Vol:41, ISSN:0893-133X, Pages:2647-2657

More Publications